Research Studies in Social Anxiety
 

Brain Imaging in Social Anxiety Disorder
(P.I. Franklin Schneier, MD; IRB#3620)                         Contact Christine Figueroa 543-6744.

Purpose: Use state-of-the-art brain imaging techniques to learn more about the brain chemistry of the
 neurotransmitter dopamine, believed to be involved in social anxiety. We hope the results of this study
will, in the future, help improve diagnosis and treatment of social anxiety problems.

You may be eligible if you: Are between the ages of 18-55
                                           Have current social anxiety problems
                                           Are not currently taking psychiatric medication

What is Involved: Psychiatric and medical evaluation, at no cost to participant
                            If eligible, brain scans (including PET and SPECT) usually
                            conducted over a 2-3 week period.

Benefits to Participant: Free, thorough clinical evaluation by psychiatrist.
After completing the study, participants will receive payment and 3 months of free treatment.
 

Escitalopram Treatment of Major Depression with Comorbid Social Anxiety Disorder
(P.I. Franklin Schneier, MD; IRB#4347)                         Contact Celeste Toribio 543-5380.

Purpose: To test the effectiveness escitalopram (Lexapro), a recently marketed antidepressant, in the
treatment of persons with both depression and social anxiety disorder.

You may be eligible if you: Are between the ages of 18-65
                                            Have current social anxiety problems and depression
                                            Are not currently taking psychiatric medication

What is Involved: Psychiatric and medical evaluation, at no cost to participant
                            If eligible, 12 weeks of treatment with escitalopram (Lexapro)
                            No placebo (sugar pill) is used in this study

Benefits to Participant: Free, thorough clinical evaluation by psychiatrist.
Escitalopram treatment may improve symptoms of depression and social anxiety disorder.
After completing the study, participants will receive 3 months of free treatment.